
Bioorganic and Medicinal Chemistry Letters p. 127 - 132 (1999)
Update date:2022-08-05
Topics:
Reiter, Lawrence A.
Rizzi, James P.
Pandit, Jayvardan
Lasut, Michael J.
McGahee, Shunda M.
Parikh, Vinod D.
Blake, James F.
Danley, Dennis E.
Laird, Ellen R.
Lopez-Anaya, Arturo
Lopresti-Morrow, Lori L.
Mansour, Mahmoud N.
Martinelli, Gary J.
Mitchell, Peter G.
Owens, Brian S.
Pauly, Thomas A.
Reeves, Lisa M.
Schulte, Gayle K.
Yocum, Sue A.
Through the use of empirical and computational methods, phosphinate- based inhibitors of MMP-1 and MMP-13 that bind into the S2 pocket of these enzymes were designed. The synthesis and testing of 2 suggested that binding was occuring as hypothesized. Structure determination of a co-crystal of 2 bound to the catalytic domain of MMP-1 confirmed the binding mode. Substituents binding into S2, S1', S2' and S3', were optimized yielding compounds with low double-digit nM IC50's against these enzymes.
View MoreContact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Jinan Baozhao Pharmaceutical Co., Ltd
Contact:0086-531-86397156 82371858 82371868
Address:Huaneng Road, Jinan, Shandong ,China
Beijing ZhongDaXinHe Chemical Product Co.,Ltd(expird)
Contact:010-52876516
Address:tongzhoubeiyuan
website:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
Doi:10.1021/om401184n
(2014)Doi:10.1016/S0031-9422(00)00473-8
(2001)Doi:10.1002/chem.201403161
(2014)Doi:10.1016/j.catcom.2013.12.012
(2014)Doi:10.1248/cpb.42.739
(1994)Doi:10.1016/S0040-4039(00)61549-6
(1993)